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Abstract
Introduction Induction of mild hypothermia after cardiac arrest
may confer neuroprotection. We assessed the feasibility, safety
and effectiveness of therapeutic infusion of 2 l of normal saline
at 4°C before return of spontaneous circulation during
cardiopulmonary resuscitation after out of hospital cardiac
arrest.
Methods This was a prospective, observational, multicenter
clinical trial conducted in Emergency Medical Services units and
in a medical intensive care unit at Caen University Hospital, Cen,
France.
Results In patients who had suffered out of hospital cardiac
arrest, hypothermia was induced by infusing 2 l of 4°C NaCl
0.9% over 30 minutes during advanced life support prior to
arrival at the hospital. A total of 33 patients were included in the
study. Eight patients presented with ventricular fibrillation as the
initial cardiac rhythm. Mild hypothermia was achieved after a
median of 16 minutes (interquartile range 11.5 to 25.0 minutes)
after return of spontaneous circulation. After intravenous
cooling, the temperature decreased by 2.1°C (P < 0.0001) to a
mean body temperature of 33.3°C (interquartile range 32.3 to
34.3°C). The only observed adverse event was pulmonary
oedema, which occurred in one patient.
Conclusion We concluded that prehospital induction of
therapeutic hypothermia using infusion of 2 l of 4°C normal
saline during advanced life support was feasible, effective and
safe. Larger studies are required to assess the impact that this
early cooling has on neurological outcomes after cardiac arrest.
Introduction
Out of hospital cardiac arrest (OHCA) is common and associ-
ated with a poor outcome, despite improvements in cardiopul-
monary resuscitation (CPR) [1,2]. Two major complications
may occur after resuscitation from cardiac arrest. The first is
postresuscitation disease, which occurs between 4 and 24
hours after resuscitation and is characterized by an ischaemia/
reperfusion syndrome and a systemic inflammatory response
syndrome [3]. The second complication is severe anoxic brain
injury, which kills two-thirds of survivors [3,4].
In a hospital setting, mild hypothermia induced 4 to 8 hours
after OHCA improves the outcomes of comatose survivors in
whom ventricular fibrillation (VF) is the initial rhythm [5,6], and
this strategy is currently recommended by the International
Liaison Committee On Resuscitation [7]. Using external or
endovascular cooling devices, it takes 219 to 480 minutes to
achieve cooling to 33°C [6,8,9]. Infusion of cold crystalloids
after hospital admission effectively lowers body temperature in
resuscitated patients [10,11]. However, studies of animal
models of cardiac arrest suggest that the timing of induced
hypothermia is a major determinant of survival [12,13]. In an
animal model early cooling resulted in significantly better neu-
rological outcomes than did delayed cooling after return of
spontaneous circulation (ROSC) or normothermic resuscita-
tion [12]. In addition, a recent case report conducted by Ber-
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nard and coworkers [14] suggested that inducing cooling
before ROSC may be advantageous.
In the present study we aimed to determine the feasibility,
safety and effectiveness of cooling patients before ROSC dur-
ing advanced life support (ALS) in the field before their arrival
at the emergency department.
Materials and methods
Study protocol
This prospective, observational, clinical trial was conducted
between October 2004 and October 2006 and involved both
Emergency Medical Services (EMS) and the medical intensive
care unit (ICU) at the University Hospital in Caen, France. This
study was supported by an academic grant (registration
number 2004-R-58) and was approved by the Institutional
Ethics Committee of Caen University Hospital, in accordance
with the European Guidelines for Good Clinical Practice. In
accordance with French law, the next of kin were orally
informed about the trial by the prehospital emergency team at
the time of inclusion, and written consent was systematically
obtained from participants' next of kin within 24 hours. Further-
more, written consent was obtained from all survivors.
Study design
Consecutive comatose patients aged 18 to 70 years suffering
nontraumatic OHCA were eligible, regardless of their initial
cardiac rhythm. Patients with the following were excluded:
pregnancy; response to verbal commands after the ROSC;
traumatic aetiology of cardiac arrest; and enrollment in another
study.
Patients were treated in accordance with current European
Resuscitation Council guidelines [15]. After ROSC, patients
were ventilated manually and ECG (Lifepak®12; Medtronic
PhysioControl, Redmond, WA, USA), pulsatile oxygen satura-
tion (Oximax®; Nellcor, Pleasantan, CA, USA) and end-tidal
carbon dioxide (FilterLine® H Set; Medtronic PhysioControl)
were monitored continuously. The arterial blood pressure was
measured noninvasively every 5 minutes and the oesophageal
temperature was monitored continuously using the Data
Therm™ monitor for adults (Medical Geratherm AG, Gesch-
wenda, Germany). EMS physicians placed oesophageal tem-
perature probes after tracheal intubation in all patients.
Cooling was performed as soon as possible during ALS by
EMS personnel. The EMS team was composed of one physi-
cian and two paramedics, who did not require special training.
Specifically, hypothermia was induced during ALS at the
arrival of EMS by infusing 2 l of NaCl 0.9% at 4°C over 30 min-
utes. The ice-cold normal saline was infused through a periph-
eral intravenous line that was 18 gauge or larger, using a
pressure bag inflated to 300 mmHg. All patients were sedated
after ROSC by ketamine hydrochloride (1 mg/kg per hour)
with fentanyl (1.5 μg/kg per hour) for sedation and received
atracurium (0.5 mg/kg per hour) to prevent shivering. The clin-
ical trial required equipment to be added to the EMS units.
One-litre bags of normal saline were stored in a refrigerator at
4°C before use, and each EMS unit was equipped with refrig-
erators capable of storing several 1 l bags of normal saline at
4°C. In the hospital, hypothermia was continued for 24 hours
using an endovascular cooling catheter (Icy™ Catheter; Alsius,
Irvine, CA, USA), which was inserted into the inferior vena
cava via the right or left femoral vein and connected to a cool-
ing device (Coolgard 3000™; Alsius) in the ICU. The oesopha-
geal temperature was recorded online and the target
temperature was 33 ± 1°C. Patients were then rewarmed
within 24 hours to 37°C. The study is summarized in Figure 1.
Data collection
In addition to baseline resuscitation characteristics, including
both clinical and biological data, we monitored body tempera-
ture at the following times: before the induction of mild hypo-
thermia (step 0), after the rapid infusion of normal saline at 4°C
(step 1), upon arrival in the emergency room (step 2), in the
ICU (step 3), and after 30 minutes (step 4) and 12 hours (step
5) of use of the endovascular cooling device. EMS personnel
also recorded temporal data: the no-flow interval (time
between patient collapse and initiation of CPR), the low-flow
interval (time from beginning of CPR to ROSC), and the time
from the ROSC to target temperature (<34°C). Baseline clin-
ical and laboratory data recorded in the emergency room
included blood gas analysis, blood levels of sodium, potas-
sium, chloride, calcium, serum albumin, serum urea nitrogen,
serum creatinine, haematocrit, haemoglobin, white blood cell
count and platelet count. Adverse events, including bleeding,
arrhythmia (ventricular fibrillation or tachycardia), pulmonary
oedema and electrolyte disturbances, were also recorded.
Neurological outcome at 6 months was assessed using the
five-grade Glasgow-Pittsburgh Cerebral Performance Cate-
gories (CPC) [16]. A favorable neurological outcome was
defined as a CPC of 1 (good cerebral performance) or 2 (mod-
erate cerebral disability) on a five-category scale; the other
categories were 3 (severe cerebral disability), 4 (coma or veg-
etative state) and 5 (death). Patients with good recovery or
moderate disability had sufficient cerebral function to live inde-
pendently and work at least part time.
Statistical analysis
Quantitative variables were expressed as mean ± standard
deviation or median (interquartile range), as appropriate. Qual-
itative variables were expressed as numbers and percentages.
All consecutive patients were included in the assessment of
the effectiveness of lowering body temperature (between
steps 0 and 1), in accordance with the intent-to-treat principle.
In order to modelize body temperature with time (steps 0 to 5),
we used the concept of mixed models with random intercepts
to account for repeated measurements within the survivor
group. All statistical analyses were performed using Epi-InfoAvailable online http://ccforum.com/content/12/1/R31
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V6 (Centers for Disease Control and Prevention, Atlanta, GA,
USA) and SAS V9.1.3 (SAS Institute Inc., Cary, NC, USA). P
< 0.05 was considered statistically significant.
Results
Thirty-three patients were included in this study (Figure 1). The
baseline characteristics of the patients are shown in Table 1.
In the 33 patients, the mean temperature decreased signifi-
cantly (P  < 0.0001) by -2.1°C ± 0.29°C after intravenous
cooling to a median temperature of 33.3°C (32.3°C to
34.3°C). Twenty of the 33 (60.6%) were successfully resusci-
tated. The median time to reach mild hypothermia (<34°C)
after ROSC was 16 minutes (11.5 minutes to 25.0 minutes).
Eleven patients survived and were admitted to the ICU, where
the endovascular cooling device was used. Boxplots of
patients' body temperatures according to different resuscita-
tion steps are shown in Figure 2. In this subgroup, tempera-
tures before (step 0) and after (step 1) infusion of 4°C normal
saline decreased significantly by -2.4°C ± 0.43°C (P  <
0.0003). The temperatures in the kinetics curve revealed non-
significantly passive rewarming, with a +0.26°C ± 0.35 of tem-
perature variation (p = 0.48) between the end of cold normal
saline infusion (step 1) and admission to the ICU (step 3).
However, the patients' body temperatures were always signif-
icantly lower upon hospital admission (step 2; P < 0.004; tem-
perature difference -1.13°C ± 0.28°C) and upon ICU
admission (step 3; P < 0.02; temperature difference of -0.6°C
± 0.21°C) than their initial temperature before cooling (step 0).
Figure 1
Study design and protocol Study design and protocol. 1Induction: hypothermia was induced by infusion via peripheral intravenous line of 2000 ml of NaCl 0.9% at 4°C. 
2Maintenance hypothermia was achieved by endovascular cooling using Coolgard 3000™, with a target core temperature of 33°C over 24 hours. 
3Rewarming was by endovascular warming by Coolgard 3000™ from 33°C to 37°C over 24 hours. ALS, advanced life support; EMS, Emergency 
Medical Services; ICU, intensive care unit; ILCOR, International Liaison Committee On Resuscitation; OHCA, out of hospital cardiac arrest; ROSC, 
return of spontaneous circulation. CPC M6: Neurological status was evaluated at 6 months using the Pittsburgh Cerebral Performance Category 
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Only one patient developed pulmonary oedema, which was
characterized by clinical features as well as decreased pulsa-
tile oxygen saturation; development of oedema prompted
interruption of cold saline infusion after 1500 ml. There were
no adverse events involving bleeding, and neither did any
arrhythmia occur. Moreover, we did not observe any cases of
re-arrest during transport to the hospital. There were no clini-
cally relevant changes in the biological data recorded at the
hospital (Table 1). Fluid loading did not induce haemodilution;
the median haematocrit was 39.1% (36.4% to 40.7%). The
pH of the arterial blood gas, 7.16 (7.02 to 7.23), exhibited a
lactic acidaemia.
Finally, EMS personnel reported no technical difficulties in
implementing the protocol.
At 6 months after OHCA, four patients survived, three with a
favorable neurological outcome (CPC ≤ 2). The primary
adverse effect was anterograde amnesia. The initial cardiac
rhythms of these four patients were VFs in three patients and
asystole in one.
Discussion
This study shows that rapid infusion of 2 l of normal saline at
4°C in the field during ALS after OHCA and before ROSC
was feasible, effective and safe in terms of decreasing body
temperature before arrival at the hospital. We used a standard
dose of 2 l instead of a weight-based dose in order to develop
an easily managed protocol for treatment of OHCA patients in
the field. With early cooling, we observed an ROSC rate of
60.6%; there were no adverse effects associated with the infu-
Table 1
Baseline characteristics
Parameter Value
Age (years) 53 (47 to 65)
Men (n [%]) 26 (78.7)
Witnessed cardiac arrest (n [%]) 26 (78.7)
Basic life support (n [%]) 9 (34.6)
Ventricular fibrillation (n [%]) 8 (24.3)
Asystole plus pulseless electrical activity (n [%]) 25 (75.7)
Defibrillations (n) 1 (0 to 4)
Epinephrin (mg) 15 (4 to 20)
End-tidal carbon dioxide at ROSC (mmHg) 33 (19 to 47)
No-flow time (minutes) 10 (5 to 14)
Low-flow time (minutes)a 16 (11.5 to 25)
Time from collapse to ROSC (minutes)a 25 (20.2 to 35.7)
Time from ROSC to mild hypothermia (minutes)a 16 (11.5 to 25)
PaO2/FiO2
b 300 (159 to 403)
pH arterial blood gasb 7.16 (7.02 to 7.23)
Lactates (mmol/l)b 9.5 (3.7 to 11.3)
Serum creatinine (μmol/l)b 147 (94 to 179)
Sodium (mmol/l)b 138 (136 to 139)
Potassium (mmol/l)b 4.1 (3.8 to 4.5)
Calcemia (mmol/l)b 2.1 (2.1 to 2.3)
Chloride (mmol/l)b 107 (101 to 109)
Haemoglobin (g/dl)b 12.9 (11.9 to 13.4)
Haematocrit (%)b 39.1 (36.4 to 40.7)
Platelet count (g/l)b 165,500 (88,000 to 208,000)
Data are presented as median and their interquartile range or as numbers (percentages). aTwenty out of 33 patients successfully resuscitated. 
bBiological data among 11 patients admitted to the intensive care unit. FiO2, fraction of inspired oxygen; PaO2, arterial partial oxygen tension.Available online http://ccforum.com/content/12/1/R31
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sion of 2 l of ice-cold normal saline during ALS, except for
oedema, which developed in one patient. The time from wit-
nessed cardiac arrest to initial treatment, as well as delays
from OHCA to CPR and to ROSC, were similar to those in
previous reports [5,6,10,11]. The no-flow time, which was 10
minutes (5 minutes to 14 minutes), was consistant with the cri-
teria for inclusion in the HACA (Hypothermia After Cardiac
Arrest) Study Group trial [6]. The median delay between the
OHCA and ROSC (25 minutes [20.2 minutes to 37.5 min-
utes]) was comparable to that reported by Bernard and cow-
orkers [10] (26 minutes [20.3 minutes to 34.5 minutes]) and
Kliegel and colleagues [11] (20 minutes [13 minutes to 29
minutes]).
Inducing mild hypothermia during ALS, as compared with
post-ROSC early cooling [17,18], may reduce the duration of
cerebral ischaemic injury. In experimental models [12,13,19],
the time to induce hypothermia was closely correlated with
anoxic neurological injury. In the animal model described by
Nozari and coworkers [19], 17 dogs had VF cardiac arrest
with a no-flow of 3 minutes, followed by 7 minutes of CPR
basic life support and 50 minutes of ALS. The dogs were ran-
domly assiged to two treatment groups: an early hypothermia
group (34°C), in which cooling was initiated at 10 minutes of
VF during ALS, and a delayed hypothermia group, in which
colling was initiated at 20 minutes of VF. In the early hypother-
mia group, seven out of nine dogs survived to 96 hours, five
with good neurological outcome. In contrast, seven of eight
dogs in the delayed hypothermia group died within 37 hours
with multiple organ failure (P = 0.012) [19]. Consequently, a
small reduction in the delay between cardiac arrest and thera-
peutic hypothermia may improve neurological outcome after
resuscitation. The present study confirmed the feasibility and
effectiveness of cooling with a rapid infusion of cold fluid, as
was previously reported [10,11,17,18]. Lowering tempera-
tures by infusion of normal saline at 4°C was more effective in
this study than in the other studies [10,11,17,18]; we
achieved a mean temperature decrease of 2.1°C ± 0.29°C
and a median body temperature of 33.3°C (32.3°C to 34.3°C;
step 1). Differences in the cooling protocol could account for
this finding. Recently, Kämäräinen and coworkers [20]
observed a decrease of 2.5°C (nasopharyngeal temperature)
in five patients after paramedics infused 14 ml/kg of Ringer's
acetate at 4°C during CPR; four patients died in the field.
Once the target temperature was reached, patients remained
within the temperature range of 32°C to 34°C. Hypothermia
induced in the field persisted from the end of infusion until
admission to the ICU. However, rewarming was reported by
Kliegel and colleagues [21], who proposed maintenance of
Figure 2
Boxplots of body temperatures Boxplots of body temperatures. Figure 2 contains six boxplots for 11 patients who received endovascular cooling. On the x-axis and for each boxplot, 
the number corresponds to the differents steps; the y-axis shows body temperatures. The shaded box denotes the middle 50% of the data, and 
hence the lower and upper ends of the box denote the 25th and 75th percentiles, respectively. The solid black horizontal line through each shaded 
box denotes the median of the distribution and the black cross denotes the mean. The vertical solid black lines ('whiskers') reach out to 1.5× the 
interquartile range. Circles above the whiskers denote individual extreme observations. Step 0: temperature before infusion of 2 l of NaCl 0.9% at 
4°C; step 1: temperature at the end of perfusion; step 2: initial temperature in emergency room; step 3: initial temperature in ICU; step 4: tempera-
ture after 30 minutes of endovascular cooling (Coolgard 3000™); and step 5: temperatures after 12 hours of endovascular cooling (Coolgard 
3000™). *P < 0.05.Critical Care    Vol 12 No 1    Bruel et al.
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mild hypothermia by repeated cold infusions. The conse-
quences of these thermal deviations for cerebral metabolism
remain unknown. Because the cerebral metabolic rate
decreases by 6% to 7% for each 1°C decrease in temperature
[22], it could be preferable to continue the 'cold chain' without
interruption until admission to the ICU.
A major concern about rapidly infusing cold fluid in the field is
the possibility of inducing pulmonary oedema in resuscitated
patients. In the present study, initiating hypothermia during
ALS before ROSC reduced volume infusion during resuscita-
tion and possibly decreased the risk for development of pul-
monary oedema. All patients except one received 2 l of cold
fluid loading, and the median arterial oxygen tension/fraction of
inspired oxygen ratio of patients who survived to ICU admis-
sion was 300 (159 to 403). This study confirms the safety of
infusing a large volume of cold fluid, consistent with the find-
ings of an echocardiographic study [23] and with those of
other studies that tested the safety and effectiveness of this
cooling procedure [10,11,17,18]. Kim and coworkers [23]
demonstrated that fluid loading with 2 l of normal saline at 4°C
had no significant effect on left ventricular function, left atrial
filling pressures, pulmonary artery pressure, or central venous
pressure. Bernard [10] and Kliegel [11] and their colleagues
did not observe pulmonary oedema after infusion of cold
Ringer's solution in any of the 22 or 26 patients, respectively,
included in their studies. However, these trials were con-
ducted after hospital admission rather than before. In-field
cooling was not associated with pulmonary oedema, as initially
assessed by chest radiography, in the recent clinical trial con-
ducted by Kim and coworkers [23]; however, only 12 patients
out of 63 received the 2 l of cold normal saline after ROSC.
Virkkunen and colleagues [18] also found no pulmonary
oedema after prehospital infusion of cold Ringer's solution. In
addition, we did not observe bleeding complications or meta-
bolic disturbances in any patients included in the present
study.
We are aware that this study has limitations. Specifically, there
was no control group with which to compare changes in body
temperature, renal function, or electrolyte disorders. However,
the results of this feasibility study now make it ethically accept-
able to conduct a larger, multicentre, randomized trial to
assess whether prehospital induced cooling after OHCA con-
fers neurological benefits.
Conclusion
We conclude that infusion of 2 l of normal saline at 4°C in the
field during ALS to induce mild hypothermia in resuscitated
OHCA patients is feasible, safe and effective. This approach
could represent the earliest and most cost-effective neuropro-
tective strategy.
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